Finance

Beta
Lists
VEEV:VIE
Veeva Systems Inc
€156.15
+1.73%
(+2.65) 1D
Jun 5, 3:30:39 PM GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for VEEV...
Open
€152.95
High
€156.15
Low
€152.75
Mkt. cap
28.39B
Avg. vol.
7.00
Volume
217.00
52-wk high
€264.30
52-wk low
€128.20
No. of employees
8K
Open
€152.95
High
€156.15
Low
€152.75
Mkt. cap
28.39B
Avg. vol.
7.00
Volume
217.00
52-wk high
€264.30
52-wk low
€128.20
No. of employees
8K
News stories
From sources across the web
Profile
Veeva Systems Inc., headquartered in Pleasanton, California, provides cloud computing software, data, and consulting services for the life sciences industry. Its products are used to track all aspects of drug development and pharmaceutical manufacturing. The company has 1,552 customers including Bayer, Boehringer Ingelheim, Eli Lilly and Company, Gilead Sciences, Merck & Co., Novartis, Alkermes plc, Alnylam Pharmaceuticals, bluebird bio, and Idorsia. Its primary competitor for its customer relationship management software is Salesforce, which is partnered with IQVIA. Wikipedia
About Veeva Systems Inc
CEOPeter Gassner
Employees7.93K
Founded2007
HeadquartersPleasanton, California, United States
SectorHealth care
Websiteveeva.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jul 2025
Oct 2025
Jan 2026
Apr 2026
Revenue
789.08M
811.24M
835.95M
882.95M
Cost of goods sold
195.25M
199.46M
213.48M
220.92M
Cost of revenue
195.25M
199.46M
213.48M
220.92M
Research and development expenses
192.68M
191.88M
198.79M
208.32M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
174.62M
179.04M
177.80M
180.59M
Operating expense
367.29M
370.92M
376.60M
388.91M
Total operating expenses
562.55M
570.38M
590.08M
609.84M
Operating income
226.54M
240.85M
245.88M
273.11M
Other non operating income
69.46M
-
934.00K
74.42M
EBT including unusual items
265.36M
312.79M
317.54M
347.53M
EBT excluding unusual items
295.99M
312.79M
315.70M
347.53M
Income tax expense
65.06M
76.58M
73.33M
86.59M
Effective tax rate
24.52%
24.48%
23.09%
24.92%
Other operating expenses
-
-
-
-
Net income
200.31M
236.20M
244.20M
260.94M
Net profit margin
25.39%
29.12%
29.21%
29.55%
Earnings per share
1.99
2.04
2.06
2.24
Interest and investment income
-
71.93M
74.35M
-
Interest expense
-
-
-
-
Net interest expenses
-
71.93M
74.35M
-
Depreciation and amortization charges
-
-
-
-
EBITDA
236.66M
250.56M
254.19M
284.70M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer